Related Experiment Video
Updated: Mar 6, 2026

Dynamic Clamp Methods to Investigate Impaired Neuronal Excitability Associated with Autism
Published on: October 17, 2025
A late-diagnosed phenylketonuria case presenting with autism spectrum disorder in early childhood
Betül Mazlum1, Banu Anlar2, H Serap Kalkanoğlu-Sivri3
1Department of Neuroscience, İstanbul University, Experimental Medicine Research Institute, İstanbul, Turkey.
Insights
Phenylketonuria (PKU), an inherited metabolic disorder, can present with autism symptoms. Early diagnosis and treatment are crucial to prevent severe brain damage in children with PKU.
Area of Science:
- Genetics
- Metabolic Disorders
- Neurodevelopmental Disorders
Background:
- Phenylketonuria (PKU) is a common autosomal recessive disorder in Turkey.
- Untreated PKU can lead to severe neurological impairment, including autism spectrum disorder (ASD) in some cases.
Observation:
- A case of a three-year-old boy presenting with autism symptoms who was diagnosed with PKU is detailed.
- This case highlights the potential for metabolic disorders like PKU to be missed in children with autism, especially with widespread newborn screening.
Findings:
- The study discusses potential pathogenetic mechanisms linking PKU to autistic symptoms.
- It emphasizes that even with newborn screening, some PKU cases might be overlooked due to incomplete screening coverage or pre-test dietary factors.
Implications:
- Clinicians should consider treatable metabolic disorders, such as PKU, in the differential diagnosis of autism.
- This underscores the importance of considering metabolic causes in children with unexplained neurological symptoms, even when seemingly unlikely.
Abstract:
Phenylketonuria is one of the most prevalent autosomal recessive hereditary disorders in Turkey. If untreated, it results in severe brain damage and can also be associated with autism in certain patients. We present a three-year old boy who exhibited the symptoms of autism and was subsequently diagnosed with phenylketonuria. This case illustrates that because the majority of autism cases are idiopathic, an occasional patient with a metabolic disorder might be overlooked especially in the era of newborn screening. We also discuss the possible pathogenetic processes leading to autistic symptoms in phenylketonuria, and wish to draw attention to the possibility of cases missed in the screening program because of less than 100% coverage or insufficient food intake before blood sampling. Clinicians should keep in mind the possibility of treatable disorders in children with autism even when such disorders appear unlikely.
Related Concept Videos
Inborn Errors of Metabolism
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pedigree Analysis
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....

